|
|
Imagination of novel targeted molecular imaging probes in the early diagnosis of upper urinary tract epithelial carcinoma model |
LIAO Guodong1, WANG Lijiang2, YU Weiwen1, ZHANG Jianshe3. |
1.Department of Urology, Zhejiang Provincial People’s Hospital, Hangzhou, 310014; 2.Zhejiang University California International Nanosystems Institute, Zhejiang University, Hangzhou, 310027; 3.School of Basic Medical Science, Wenzhou Medical University, Wenzhou, 325035 |
|
Cite this article: |
LIAO Guodong,WANG Lijiang,YU Weiwen, et al. Imagination of novel targeted molecular imaging probes in the early diagnosis of upper urinary tract epithelial carcinoma model[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2017, 47(8): 547-552.
|
|
Abstract Objective: To investigate the characteristic and tumor targeting of up-converting phosphor (UCP) nano-probe in labeling orthotopic transplantation tumor of early upper urinary tract urothelial carcinoma in vivo. Methods: Water soluble UCP was synthesized by high temperature pyrolysis. Then, UCP was link to the pH (low) insertion peptide (pHLIP). Imaging of urothelial tumors in a tumor bearing animal model by pHLIP-UCP probe was proceeded using a small animal in vivo multispectral Maestro imaging system (CRI). Results: NaYF4:Yb3+, Er3+ upconversion nanocrystals were synthesized with good dispersibility, small particle size and high solution permeability. The upconversion luminescence signal of the UCP nanoprobe had stable luminescence and high sensitivity in the dark environment. Conclusion: The UCP nanoprobe can specifically bound to orthotopic transplanted tumor of upper urinary tract urothelial cancer in vivo, which shows the potential for in vivo imaging of early upper urinary tract epithelial carcinoma.
|
Received: 16 January 2017
|
|
|
|
|
[1] ROUPRÊT M, ZIGEUNER R, PALOU J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update[J]. Eur Urol, 2011, 59(4): 584-594.
[2] PICOZZI S, RICCI C, GAETA M, et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients[J]. J Urol, 2012, 188(6): 2046-2054.
[3] POON C Y, WEI L, XU Y, et al. Quantification of cancer biomarkers in serum using scattering-based quantitative single particle intensity measurement with a dark-field microscope[J]. Anal Chem, 2016, 88(17): 8849-8856.
[4] GARCIA K E, BABANOVA S, SCHEFFLER W, et al. Designed protein aggregates entrapping carbon nanotubes for bioelectrochemical oxygen reduction[J]. Biotechnol Bioeng, 2016, 113(11): 2321-2327.
[5] AINBINDER D, TOUITOU E. Testosterone ethosomes for enhanced transdermal delivery[J]. Drug Deliv, 2005, 12(5): 297-303.
[6] SHAN J, QIN X, YAO N, et al. Synthesis of monodisperse hexagonal NaYF4:Yb, Ln (Ln=Er, Ho and Tm) upconversion nanocrystals in TOPO[J]. Nanotechnology, 2007, 18(44): 445607.
[7] BUS M T, DE BRUIN D M, FABER D J, et al. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications[J]. J Endourol, 2015, 29(2): 113-123.
[8] DE DOMINICIS C, LIBERTI M, PERUGIA G, et al. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity[J]. Urology, 2001, 57(6): 1059-1062.
[9] FOTINOS N, CAMPO M A, POPOWYCZ F, et al. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives[J]. Photoehem Photobiol, 2006, 82(4): 994-1015.
[10] OLIVO M, LAU W, MANIVASAGER V, et al. Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin[J]. Int J Oncol, 2003, 23(6): 1501-1504.
[11] HUCK C W, OZAKI Y, HUCK-PEZZEI V A. Critical review upon the role and potential of fluorescence and near-Infrared imaging and absorption spectroscopy in cancer related cells, serum, saliva, urine and tissue analysis[J]. Curr Med Chem, 2016, 23(27): 3052-3077.
[12] CHATTERJEE D K, ZHANG Y. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells[J]. Nanomedicine, 2008, 3(1): 73-82.
[13] CHATTERJEE D K, RUFAIHAH A J, ZHANG Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals[J]. Biomaterials, 2008, 29(7): 937-943.
[14] LIOTTA L A, KOHN E C. The microenvironment of the tumour-host interface[J]. Nature, 2001, 411(17): 375-379.
[15] RAGHUNAND N, GATENBY R A, GILIES R J. Microenvironmental and cellular consequences of altered blood flow in tumours[J]. Br J Radiol, 2003, 76(1): s11-s22.
[16] ANDREEV O A, DUPUY A D, SEGALA M, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo[J]. Proc Natl Acad Sci U S A, 2007, 104(19): 7893-7898. |
|
|
|